期刊文献+

N-末端脑利钠肽前体检测对心源性脑栓塞的早期诊断价值 被引量:2

Early Diagnostic Value of N-terminal Pro-brain Natriuretic Peptide on Patient with Cardioembolism
下载PDF
导出
摘要 目的:探讨血浆N-末端脑利钠肽前体(NT-proBNP)检测对心源性脑栓塞(CE)的早期诊断价值。方法:急诊收治入院的200例急性脑梗死患者,按照TOAST分型标准进行分为大动脉粥样硬化型(n=58)、小动脉闭塞型(n=76)、心源性脑栓塞(n=41)、其他明确病因型(n=15)和不明原因型(n=10),比较各型在急诊检测的NT-proBNP水平。结果:CE组患者血浆NT-proBNP水平显著高于TOAST其他亚型组(P均<0.01),其他亚型组间的NT-proBNP无明显差异。当NT-proBNP取值(cut-off值)为412.42 pg/ml时,将CE组与其他TOAST各亚型组筛选出的敏感度为75.0%,特异度为88.7%。结论:急性脑梗死中,CE患者血浆NT-proBNP水平显著升高,急诊检测血浆NT-proBNP水平有助于CE的及早诊断。 Objective: To explore the early diagnostic value of N-terminal pro-brain natriuretic peptide (NT- proBNP) in patients with cardioembolism. Methods:200 patients with acute cerebral infarction in departments of emergency were classified according to the TOAST criteria: large artery atherosclerosis (LAA ,n=58), small artery occlusion lacunar (SAO, n =76), cardioembolism (CE, n =41 ), stoke of other demonstrated etiology (SOE, n = 15 ) and stoke of other undermonstrated etiology (SUE,n=10). The NT-proBNP level of plasma were compared among the groups. Results: The NT-proBNP levels of plasma in patients with CE group was significantly higher than that of non CE group (all P 〈0.01),and all the non CE group had no significant difference. The cut-off values,sensitivity, specificity of the plasma NT-proBNP concentration suitable to distinguish CE from non-CE:412.42pg/ml,75.0%, 88.7%, P 〈 0.01. Conclusions: Early detection of plasma NT-proBNP levels in emergency department contribute to the early diagnosis of cardioembolism.
出处 《岭南急诊医学杂志》 2014年第5期381-383,共3页 Lingnan Journal of Emergency Medicine
关键词 N-末端脑利钠肽前体 心源性脑栓塞 早期诊断 急诊 NT-proBNP acute ischemic stroke TOAST criteria cardioembolism emergency department
  • 相关文献

参考文献4

二级参考文献48

  • 1吴丽娥,刘鸣,张月辉,赵晓玲,杨杰,谈颂,张世洪,吴波,谭燕,王清芳,王丽春,李伟.缺血性脑卒中TOAST病因分型和预后[J].中华神经科杂志,2004,37(4):292-295. 被引量:87
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 3Kolominsky-Rabas PL,Weber M,Gefeller O,et al.Epidemiology of ischemic stroke subtypes according to TOAST criteria:incidence,recurrence,and long-term survival in ischemic stroke subtypes:a population-based study.Stroke,2001,32:2735-2740.
  • 4Brott T,Bogousslavsky J.Treatment of acute ischemic stroke.N Engl J Med,2000,343:710-722.
  • 5Parteghini M.Role and importance of biochemical markers in clinical cardioloy.Eur Heart J,2004,25:1187-1196.
  • 6Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain.Nature,1988,332:78-81.
  • 7Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.J Card Fail,2000,6:92-96.
  • 8Nakagawa K,Yamaguchi T,Seida M,et al.Plasma concentrations of brain natriuretie-peptide in patients with acute ischemic stroke.Cerebrovasc Dis,2005,19:157-164.
  • 9M(a)kikallio AM,M(a)kikallio TH,Korpelainen JT,et al.Natriuretic peptides and mortality after stroke.Stroke,2005,36:1016-1020.
  • 10Montaner J,Perea-Gainza M,Delgado P,et al.Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.Stroke,2008,39:2280-2287.

共引文献12

同被引文献13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部